LOCUS       NM_004343               1929 bp    mRNA    linear   PRI 11-MAY-2014
DEFINITION  Homo sapiens calreticulin (CALR), mRNA.
ACCESSION   NM_004343
VERSION     NM_004343.3  GI:209862753
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 1929)
  AUTHORS   Rotunno G, Mannarelli C, Guglielmelli P, Pacilli A, Pancrazzi A,
            Pieri L, Fanelli T, Bosi A and Vannucchi AM.
  CONSRTM   Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano
            Malattie Mieloproliferative Investigators
  TITLE     Impact of calreticulin mutations on clinical and hematological
            phenotype and outcome in essential thrombocythemia
  JOURNAL   Blood 123 (10), 1552-1555 (2014)
   PUBMED   24371211
  REMARK    GeneRIF: Patients carrying the CALR mutation had a lower risk of
            thrombosis than JAK2- and MPL-mutated patients; CALR mutation had
            no impact on survival or transformation to post-ET myelofibrosis.
REFERENCE   2  (bases 1 to 1929)
  AUTHORS   Rumi E, Pietra D, Ferretti V, Klampfl T, Harutyunyan AS, Milosevic
            JD, Them NC, Berg T, Elena C, Casetti IC, Milanesi C, Sant'antonio
            E, Bellini M, Fugazza E, Renna MC, Boveri E, Astori C, Pascutto C,
            Kralovics R and Cazzola M.
  CONSRTM   Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano
            Malattie Mieloproliferative Investigators
  TITLE     JAK2 or CALR mutation status defines subtypes of essential
            thrombocythemia with substantially different clinical course and
            outcomes
  JOURNAL   Blood 123 (10), 1544-1551 (2014)
   PUBMED   24366362
  REMARK    GeneRIF: JAK2-mutated essential thrombocythemia and polycythemia
            vera represent different phenotypes of a single myeloproliferative
            neoplasm, whereas CALR-mutated essential thrombocythemia is a
            distinct disease entity.
REFERENCE   3  (bases 1 to 1929)
  AUTHORS   Gameiro SR, Jammeh ML, Wattenberg MM, Tsang KY, Ferrone S and Hodge
            JW.
  TITLE     Radiation-induced immunogenic modulation of tumor enhances antigen
            processing and calreticulin exposure, resulting in enhanced T-cell
            killing
  JOURNAL   Oncotarget 5 (2), 403-416 (2014)
   PUBMED   24480782
  REMARK    GeneRIF: Tumor irradiation in vitro and in vivo significantly
            increased cell-surface expression of calreticulin. Increased CD8+
            T-cell-mediated lysis of lung, prostate, and breast human carcinoma
            cells was mostly dictated by the presence of calreticulin on the
            surface of tumor cells. These findings suggested a direct
            interaction between exposed calreticulin and cytotoxic T cells,
            highlighting a novel function for calreticulin.
REFERENCE   4  (bases 1 to 1929)
  AUTHORS   Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC,
            Avezov E, Li J, Kollmann K, Kent DG, Aziz A, Godfrey AL, Hinton J,
            Martincorena I, Van Loo P, Jones AV, Guglielmelli P, Tarpey P,
            Harding HP, Fitzpatrick JD, Goudie CT, Ortmann CA, Loughran SJ,
            Raine K, Jones DR, Butler AP, Teague JW, O'Meara S, McLaren S,
            Bianchi M, Silber Y, Dimitropoulou D, Bloxham D, Mudie L, Maddison
            M, Robinson B, Keohane C, Maclean C, Hill K, Orchard K, Tauro S, Du
            MQ, Greaves M, Bowen D, Huntly BJ, Harrison CN, Cross NC, Ron D,
            Vannucchi AM, Papaemmanuil E, Campbell PJ and Green AR.
  TITLE     Somatic CALR mutations in myeloproliferative neoplasms with
            nonmutated JAK2
  JOURNAL   N. Engl. J. Med. 369 (25), 2391-2405 (2013)
   PUBMED   24325359
  REMARK    GeneRIF: Somatic mutations in the endoplasmic reticulum chaperone
            CALR were found in a majority of patients with myeloproliferative
            neoplasms with nonmutated JAK2.
REFERENCE   5  (bases 1 to 1929)
  AUTHORS   Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E,
            Milosevic JD, Them NC, Berg T, Gisslinger B, Pietra D, Chen D,
            Vladimer GI, Bagienski K, Milanesi C, Casetti IC, Sant'Antonio E,
            Ferretti V, Elena C, Schischlik F, Cleary C, Six M, Schalling M,
            Schonegger A, Bock C, Malcovati L, Pascutto C, Superti-Furga G,
            Cazzola M and Kralovics R.
  TITLE     Somatic mutations of calreticulin in myeloproliferative neoplasms
  JOURNAL   N. Engl. J. Med. 369 (25), 2379-2390 (2013)
   PUBMED   24325356
  REMARK    GeneRIF: Most patients with essential thrombocythemia or primary
            myelofibrosis that was not associated with a JAK2 or MPL alteration
            carried a somatic mutation in CALR.
REFERENCE   6  (bases 1 to 1929)
  AUTHORS   Hochstrasser DF, Frutiger S, Paquet N, Bairoch A, Ravier F,
            Pasquali C, Sanchez JC, Tissot JD, Bjellqvist B and Vargas R.
  CONSRTM   et al
  TITLE     Human liver protein map: a reference database established by
            microsequencing and gel comparison
  JOURNAL   Electrophoresis 13 (12), 992-1001 (1992)
   PUBMED   1286669
REFERENCE   7  (bases 1 to 1929)
  AUTHORS   Rasmussen HH, van Damme J, Puype M, Gesser B, Celis JE and
            Vandekerckhove J.
  TITLE     Microsequences of 145 proteins recorded in the two-dimensional gel
            protein database of normal human epidermal keratinocytes
  JOURNAL   Electrophoresis 13 (12), 960-969 (1992)
   PUBMED   1286667
REFERENCE   8  (bases 1 to 1929)
  AUTHORS   McCauliffe DP, Yang YS, Wilson J, Sontheimer RD and Capra JD.
  TITLE     The 5'-flanking region of the human calreticulin gene shares
            homology with the human GRP78, GRP94, and protein disulfide
            isomerase promoters
  JOURNAL   J. Biol. Chem. 267 (4), 2557-2562 (1992)
   PUBMED   1733953
REFERENCE   9  (bases 1 to 1929)
  AUTHORS   Rokeach LA, Haselby JA, Meilof JF, Smeenk RJ, Unnasch TR, Greene BM
            and Hoch SO.
  TITLE     Characterization of the autoantigen calreticulin
  JOURNAL   J. Immunol. 147 (9), 3031-3039 (1991)
   PUBMED   1919005
REFERENCE   10 (bases 1 to 1929)
  AUTHORS   Rojiani MV, Finlay BB, Gray V and Dedhar S.
  TITLE     In vitro interaction of a polypeptide homologous to human Ro/SS-A
            antigen (calreticulin) with a highly conserved amino acid sequence
            in the cytoplasmic domain of integrin alpha subunits
  JOURNAL   Biochemistry 30 (41), 9859-9866 (1991)
   PUBMED   1911778
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC092069.2 and BC007911.1.
            This sequence is a reference standard in the RefSeqGene project.
            On Oct 21, 2008 this sequence version replaced gi:5921996.
            
            Summary: Calreticulin is a multifunctional protein that acts as a
            major Ca(2+)-binding (storage) protein in the lumen of the
            endoplasmic reticulum. It is also found in the nucleus, suggesting
            that it may have a role in transcription regulation. Calreticulin
            binds to the synthetic peptide KLGFFKR, which is almost identical
            to an amino acid sequence in the DNA-binding domain of the
            superfamily of nuclear receptors. Calreticulin binds to antibodies
            in certain sera of systemic lupus and Sjogren patients which
            contain anti-Ro/SSA antibodies, it is highly conserved among
            species, and it is located in the endoplasmic and sarcoplasmic
            reticulum where it may bind calcium. The amino terminus of
            calreticulin interacts with the DNA-binding domain of the
            glucocorticoid receptor and prevents the receptor from binding to
            its specific glucocorticoid response element. Calreticulin can
            inhibit the binding of androgen receptor to its hormone-responsive
            DNA element and can inhibit androgen receptor and retinoic acid
            receptor transcriptional activities in vivo, as well as retinoic
            acid-induced neuronal differentiation. Thus, calreticulin can act
            as an important modulator of the regulation of gene transcription
            by nuclear hormone receptors. Systemic lupus erythematosus is
            associated with increased autoantibody titers against calreticulin
            but calreticulin is not a Ro/SS-A antigen. Earlier papers referred
            to calreticulin as an Ro/SS-A antigen but this was later disproven.
            Increased autoantibody titer against human calreticulin is found in
            infants with complete congenital heart block of both the IgG and
            IgM classes. [provided by RefSeq, Jul 2008].
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            Transcript exon combination :: BC007911.1, M84739.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
                                           ERS025081, ERS025082 [ECO:0000348]
            ##Evidence-Data-END##
            COMPLETENESS: complete on the 3' end.
PRIMARY     REFSEQ_SPAN         PRIMARY_IDENTIFIER PRIMARY_SPAN        COMP
            1-171               AC092069.2         50907-51077         c
            172-273             AC092069.2         50442-50543         c
            274-477             AC092069.2         50046-50249         c
            478-572             AC092069.2         49530-49624         c
            573-782             AC092069.2         49225-49434         c
            783-896             AC092069.2         49023-49136         c
            897-1040            AC092069.2         48790-48933         c
            1041-1133           AC092069.2         46048-46140         c
            1134-1881           AC092069.2         45217-45964         c
            1882-1929           BC007911.1         1873-1920
FEATURES             Location/Qualifiers
     source          1..1929
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="19"
                     /map="19p13.3-p13.2"
     gene            1..1929
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /note="calreticulin"
                     /db_xref="GeneID:811"
                     /db_xref="HGNC:HGNC:1455"
                     /db_xref="HPRD:00169"
                     /db_xref="MIM:109091"
     exon            1..171
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /inference="alignment:Splign:1.39.8"
     misc_feature    45..47
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /note="upstream in-frame stop codon"
     CDS             81..1334
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /note="Sicca syndrome antigen A (autoantigen Ro;
                     calreticulin); CRP55; ERp60; HACBP; grp60; calregulin;
                     endoplasmic reticulum resident protein 60; epididymis
                     secretory sperm binding protein Li 99n"
                     /codon_start=1
                     /product="calreticulin precursor"
                     /protein_id="NP_004334.1"
                     /db_xref="GI:4757900"
                     /db_xref="CCDS:CCDS12288.1"
                     /db_xref="GeneID:811"
                     /db_xref="HGNC:HGNC:1455"
                     /db_xref="HPRD:00169"
                     /db_xref="MIM:109091"
                     /translation="MLLSVPLLLGLLGLAVAEPAVYFKEQFLDGDGWTSRWIESKHKS
                     DFGKFVLSSGKFYGDEEKDKGLQTSQDARFYALSASFEPFSNKGQTLVVQFTVKHEQN
                     IDCGGGYVKLFPNSLDQTDMHGDSEYNIMFGPDICGPGTKKVHVIFNYKGKNVLINKD
                     IRCKDDEFTHLYTLIVRPDNTYEVKIDNSQVESGSLEDDWDFLPPKKIKDPDASKPED
                     WDERAKIDDPTDSKPEDWDKPEHIPDPDAKKPEDWDEEMDGEWEPPVIQNPEYKGEWK
                     PRQIDNPDYKGTWIHPEIDNPEYSPDPSIYAYDNFGVLGLDLWQVKSGTIFDNFLITN
                     DEAYAEEFGNETWGVTKAAEKQMKDKQDEEQRLKEEEEDKKRKEEEEAEDKEDDEDKD
                     EDEEDEEDKEEDEEEDVPGQAKDEL"
     sig_peptide     81..131
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /inference="COORDINATES: ab initio prediction:SignalP:4.0"
     mat_peptide     132..1331
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /product="calreticulin"
     misc_feature    132..671
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P27797.1);
                     Region: N-domain"
     misc_feature    222..224
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="N6-acetyllysine; propagated from
                     UniProtKB/Swiss-Prot (P27797.1); acetylation site"
     misc_feature    555..557
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="N6-acetyllysine; propagated from
                     UniProtKB/Swiss-Prot (P27797.1); acetylation site"
     misc_feature    651..845
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P27797.1);
                     Region: 4 X approximate repeats"
     misc_feature    672..1004
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P27797.1);
                     Region: P-domain"
     misc_feature    705..707
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="N6-acetyllysine; propagated from
                     UniProtKB/Swiss-Prot (P27797.1); acetylation site"
     misc_feature    789..890
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P27797.1);
                     Region: Interaction with PPIB (By similarity)"
     misc_feature    855..971
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P27797.1);
                     Region: 3 X approximate repeats"
     misc_feature    1005..1331
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P27797.1);
                     Region: C-domain"
     misc_feature    1320..1331
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P27797.1);
                     Region: Prevents secretion from ER"
     exon            172..273
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /inference="alignment:Splign:1.39.8"
     exon            274..477
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /inference="alignment:Splign:1.39.8"
     exon            478..572
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /inference="alignment:Splign:1.39.8"
     exon            573..782
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /inference="alignment:Splign:1.39.8"
     exon            783..896
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /inference="alignment:Splign:1.39.8"
     exon            897..1040
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /inference="alignment:Splign:1.39.8"
     exon            1041..1133
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /inference="alignment:Splign:1.39.8"
     exon            1134..1911
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /inference="alignment:Splign:1.39.8"
     STS             1345..1589
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /standard_name="STS-M84739"
                     /db_xref="UniSTS:36938"
     regulatory      1894..1899
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
                     /regulatory_class="polyA_signal_sequence"
     polyA_site      1911
                     /gene="CALR"
                     /gene_synonym="cC1qR; CRT; HEL-S-99n; RO; SSA"
ORIGIN      
        1 gcggcgtccg tccgtactgc agagccgctg ccggagggtc gttttaaagg gcccgcgcgt
       61 tgccgccccc tcggcccgcc atgctgctat ccgtgccgct gctgctcggc ctcctcggcc
      121 tggccgtcgc cgagcctgcc gtctacttca aggagcagtt tctggacgga gacgggtgga
      181 cttcccgctg gatcgaatcc aaacacaagt cagattttgg caaattcgtt ctcagttccg
      241 gcaagttcta cggtgacgag gagaaagata aaggtttgca gacaagccag gatgcacgct
      301 tttatgctct gtcggccagt ttcgagcctt tcagcaacaa aggccagacg ctggtggtgc
      361 agttcacggt gaaacatgag cagaacatcg actgtggggg cggctatgtg aagctgtttc
      421 ctaatagttt ggaccagaca gacatgcacg gagactcaga atacaacatc atgtttggtc
      481 ccgacatctg tggccctggc accaagaagg ttcatgtcat cttcaactac aagggcaaga
      541 acgtgctgat caacaaggac atccgttgca aggatgatga gtttacacac ctgtacacac
      601 tgattgtgcg gccagacaac acctatgagg tgaagattga caacagccag gtggagtccg
      661 gctccttgga agacgattgg gacttcctgc cacccaagaa gataaaggat cctgatgctt
      721 caaaaccgga agactgggat gagcgggcca agatcgatga tcccacagac tccaagcctg
      781 aggactggga caagcccgag catatccctg accctgatgc taagaagccc gaggactggg
      841 atgaagagat ggacggagag tgggaacccc cagtgattca gaaccctgag tacaagggtg
      901 agtggaagcc ccggcagatc gacaacccag attacaaggg cacttggatc cacccagaaa
      961 ttgacaaccc cgagtattct cccgatccca gtatctatgc ctatgataac tttggcgtgc
     1021 tgggcctgga cctctggcag gtcaagtctg gcaccatctt tgacaacttc ctcatcacca
     1081 acgatgaggc atacgctgag gagtttggca acgagacgtg gggcgtaaca aaggcagcag
     1141 agaaacaaat gaaggacaaa caggacgagg agcagaggct taaggaggag gaagaagaca
     1201 agaaacgcaa agaggaggag gaggcagagg acaaggagga tgatgaggac aaagatgagg
     1261 atgaggagga tgaggaggac aaggaggaag atgaggagga agatgtcccc ggccaggcca
     1321 aggacgagct gtagagaggc ctgcctccag ggctggactg aggcctgagc gctcctgccg
     1381 cagagctggc cgcgccaaat aatgtctctg tgagactcga gaactttcat ttttttccag
     1441 gctggttcgg atttggggtg gattttggtt ttgttcccct cctccactct cccccacccc
     1501 ctccccgccc tttttttttt ttttttttaa actggtattt tatctttgat tctccttcag
     1561 ccctcacccc tggttctcat ctttcttgat caacatcttt tcttgcctct gtccccttct
     1621 ctcatctctt agctcccctc caacctgggg ggcagtggtg tggagaagcc acaggcctga
     1681 gatttcatct gctctccttc ctggagccca gaggagggca gcagaagggg gtggtgtctc
     1741 caacccccca gcactgagga agaacggggc tcttctcatt tcacccctcc ctttctcccc
     1801 tgcccccagg actgggccac ttctgggtgg ggcagtgggt cccagattgg ctcacactga
     1861 gaatgtaaga actacaaaca aaatttctat taaattaaat tttgtgtctc caaaaaaaaa
     1921 aaaaaaaaa
//

